Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Senti Biosciences (SNTI) Other Gross PP&E Adjustments (2021 - 2025)

Senti Biosciences has reported Other Gross PP&E Adjustments over the past 5 years, most recently at $14.4 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 14.59% year-over-year to $14.4 million; the TTM value through Dec 2025 reached $14.4 million, down 14.59%, while the annual FY2025 figure was $14.4 million, 14.59% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $14.4 million at Senti Biosciences, down from $18.6 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $45.6 million in Q2 2023 and troughed at -$6.7 million in Q4 2021.
  • A 5-year average of $20.7 million and a median of $17.2 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 636.99% in 2022 and later crashed 65.33% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at -$6.7 million in 2021, then skyrocketed by 636.99% to $35.9 million in 2022, then plummeted by 57.53% to $15.2 million in 2023, then rose by 10.8% to $16.9 million in 2024, then fell by 14.59% to $14.4 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for SNTI at $14.4 million in Q4 2025, $18.6 million in Q3 2025, and $18.0 million in Q2 2025.